Clinical trials
Completed Phase 3 Dermatitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2008 | 1 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| Novartis Pharmaceuticals | 6 |
| Almirall, S.A. | 2 |
| EMS | 2 |
| GlaxoSmithKline | 2 |
| Incyte Corporation | 2 |
| Pfizer | 2 |
| Pierre Fabre Medicament | 2 |
| Kang Stem Biotech Co., Ltd. | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis | 31 |
| Dermatitis, Atopic | 17 |
| Eczema | 17 |
| Skin Diseases | 13 |
| Psoriasis | 5 |
| Skin Diseases, Genetic | 4 |
| Genetic Diseases, Inborn | 3 |
| Hypersensitivity | 3 |
| Hypersensitivity, Immediate | 3 |
| Immune System Diseases | 3 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.